AstraZeneca (AstraZeneca) Long-Term Capital Lease Obligation

: $857 Mil (As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

AstraZeneca's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was $857 Mil.

AstraZeneca's quarterly Long-Term Capital Lease Obligation increased from Jun. 2023 ($722 Mil) to Sep. 2023 ($744 Mil) and increased from Sep. 2023 ($744 Mil) to Dec. 2023 ($857 Mil).

AstraZeneca's annual Long-Term Capital Lease Obligation declined from Dec. 2021 ($754 Mil) to Dec. 2022 ($725 Mil) but then increased from Dec. 2022 ($725 Mil) to Dec. 2023 ($857 Mil).

AstraZeneca Long-Term Capital Lease Obligation Historical Data

The historical data trend for AstraZeneca's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

487.00

489.00

754.00

725.00

857.00

AstraZeneca Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Long-Term Capital Lease Obligation																725.00	730.00	722.00	744.00	857.00

AstraZeneca (NAS:AZN) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

AstraZeneca Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of AstraZeneca's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

AstraZeneca (AstraZeneca) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (NAS:AZN) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

AZNCF:USA AZN:Sweden AZNN:Mexico AZNl:UK AZN:UK ZEGA:Germany ZEG:Germany ZEG:Germany ZEG:Germany ZEGA:Germany ZEG:Germany A1ZN34:Brazil

Address

1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA

Website

https://www.astrazeneca.com

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.